4
results
for author:"O'Sullivan G.C."
in Literature Citations
| Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms. Deasy B.M., O'Sullivan-Coyne G., O'Donovan T.R., McKenna S.L., O'Sullivan G.C. Cancer Lett. 256:246-258(2007) · Mapped (4) |
| Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinoma. O'Sullivan G.C., Tangney M., Casey G., Ambrose M., Houston A., Barry O.P. Int. J. Cancer 121:1930-1940(2007) · Mapped (6) |
| Multireplicon genome architecture of Lactobacillus salivarius. Claesson M.J., Li Y., Leahy S., Canchaya C., van Pijkeren J.P., Cerdeno-Tarraga A.M., Parkhill J., Flynn S., O'Sullivan G.C., Collins J.K. et al. Proc. Natl. Acad. Sci. U.S.A. 103:6718-6723(2006) · UniProtKB (1,998) |
| Bcr-Abl reduces endoplasmic reticulum releasable calcium levels by a Bcl-2-independent mechanism and inhibits calcium-dependent apoptotic signaling. Piwocka K., Vejda S., Cotter T.G., O'Sullivan G.C., McKenna S.L. Blood 107:4003-4010(2006) · Mapped (26) |
